Financhill
Back

Arcus Biosciences Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
46

RCUS
Arcus Biosciences

Last Price:
15.78
Seasonality Move:
10.12%
Buy
63

ITCI
Intra-Cellular Therapies

Last Price:
89.41
Seasonality Move:
17.18%
Sell
46
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy, Sell or Hold?

  • The current Arcus Biosciences [RCUS] share price is $15.29. The Score for RCUS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RCUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $89.24. The Score for ITCI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCUS Stock Price Chart

What is Arcus Biosciences's stock price today?

  • The Arcus Biosciences share price today is $15.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing slight buying pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $89.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 39.3 Sell
Chaikin Money Flow: 55465 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.72 - 17.8) Sell
Bollinger Bands (100): (14.87 - 17.23) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 76.99 Buy
Chaikin Money Flow: 460700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.96 - 82.1) Buy
Bollinger Bands (100): (71.52 - 79.02) Buy

RCUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.88 Sell
20-day SMA: 16.94 Sell
50-day SMA: 16.64 Sell
200-day SMA: 16.34 Sell
8-day EMA: 15.89 Sell
20-day EMA: 16.4 Sell
50-day EMA: 16.46 Sell
200-day EMA: 16.59 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.69 Buy
20-day SMA: 78.21 Buy
50-day SMA: 75.65 Buy
200-day SMA: 72.06 Buy
8-day EMA: 83.84 Buy
20-day EMA: 79.81 Buy
50-day EMA: 76.91 Buy
200-day EMA: 71.78 Buy

Arcus Biosciences Earnings Growth & RCUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.36 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.

Arcus Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):